Brand A - Search Results

1

In vitro investigation of immunoglobulin treatment mechanisms in autoimmune diseases.

Brand A, Vuist WM, Van Schaik IN, Vermeulen M. Brand A, et al. Clin Exp Rheumatol. 1996 May-Jun;14 Suppl 15:S27-30. Clin Exp Rheumatol. 1996. PMID: 8828944 Review.

2

In vitro effects of polyvalent immunoglobulin for intravenous use.

van Schaik IN, Vermeulen M, Brand A. van Schaik IN, et al. Among authors: brand a. J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):15-7. doi: 10.1136/jnnp.57.suppl.15. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964843 Free PMC article. Review. No abstract available.

3

The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids.

Vuist WM, Van Schaik IN, Van Lint M, Brand A. Vuist WM, et al. Among authors: brand a. J Clin Immunol. 1997 Jul;17(4):301-10. doi: 10.1023/a:1027326731945. J Clin Immunol. 1997. PMID: 9258769

4

Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro.

van Schaik IN, Lundkvist I, Vermeulen M, Brand A. van Schaik IN, et al. Among authors: brand a. J Clin Immunol. 1992 Sep;12(5):325-34. doi: 10.1007/BF00920789. J Clin Immunol. 1992. PMID: 1430102

5

Anti-neuroblastoma cell line antibodies in inflammatory demyelinating polyneuropathy: inhibition in vitro and in vivo by IV immunoglobulin.

van Doorn PA, Brand A, Vermeulen M. van Doorn PA, et al. Among authors: brand a. Neurology. 1988 Oct;38(10):1592-5. doi: 10.1212/wnl.38.10.1592. Neurology. 1988. PMID: 2843794

6

Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis.

van Schaik IN, Bossuyt PM, Brand A, Vermeulen M. van Schaik IN, et al. Among authors: brand a. Neurology. 1995 Aug;45(8):1570-7. doi: 10.1212/wnl.45.8.1570. Neurology. 1995. PMID: 7644057

7

Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg).

van Schaik IN, Vermeulen M, van Doorn PA, Brand A. van Schaik IN, et al. Among authors: brand a. J Neuroimmunol. 1994 Oct;54(1-2):109-15. doi: 10.1016/0165-5728(94)90237-2. J Neuroimmunol. 1994. PMID: 7929799

8

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.

Vermeulen M, van Doorn PA, Brand A, Strengers PF, Jennekens FG, Busch HF. Vermeulen M, et al. Among authors: brand a. J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):36-9. doi: 10.1136/jnnp.56.1.36. J Neurol Neurosurg Psychiatry. 1993. PMID: 8429321 Free PMC article. Clinical Trial.

9

Spontaneous recovery from the Guillain-Barré syndrome is associated with anti-idiotypic antibodies recognizing a cross-reactive idiotype on anti-neuroblastoma cell line antibodies.

Lundkvist I, van Doorn PA, Vermeulen M, Brand A. Lundkvist I, et al. Among authors: brand a. Clin Immunol Immunopathol. 1993 Jun;67(3 Pt 1):192-8. doi: 10.1006/clin.1993.1064. Clin Immunol Immunopathol. 1993. PMID: 8500266

10

Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy.

van Schaik IN, Vermeulen M, van Doorn PA, Brand A. van Schaik IN, et al. Among authors: brand a. J Neurol. 1995 Sep;242(9):599-603. doi: 10.1007/BF00868814. J Neurol. 1995. PMID: 8551323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,362 results

Search Page

Filters